BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22189270)

  • 1. Small-cell carcinoma of the lung detected by CT screening: stage distribution and curability.
    Austin JH; Yip R; D'Souza BM; Yankelevitz DF; Henschke CI;
    Lung Cancer; 2012 Jun; 76(3):339-43. PubMed ID: 22189270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer.
    Silva M; Galeone C; Sverzellati N; Marchianò A; Calareso G; Sestini S; La Vecchia C; Sozzi G; Pelosi G; Pastorino U
    J Thorac Oncol; 2016 Feb; 11(2):187-93. PubMed ID: 26845115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes in patients with small cell lung cancer in a single institute: Comparative analysis of radiographic screening with symptom-prompted patients.
    Fukushima T; Tateishi K; Hanaoka M; Koizumi T
    Lung Cancer; 2015 Apr; 88(1):48-51. PubMed ID: 25703893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers.
    Cuffe S; Moua T; Summerfield R; Roberts H; Jett J; Shepherd FA
    J Thorac Oncol; 2011 Apr; 6(4):818-22. PubMed ID: 21623258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung carcinoma: staging, imaging, and treatment considerations.
    Carter BW; Glisson BS; Truong MT; Erasmus JJ
    Radiographics; 2014 Oct; 34(6):1707-21. PubMed ID: 25310425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes in patients with small cell lung cancer: comparative analysis of computed tomograpy-detected patients with others.
    Koizumi T; Fukushima T; Hamanaka K; Shiina T; Yoshida K; Kondo R; Yamamoto R; Nishizawa N
    World J Surg Oncol; 2013 Mar; 11():61. PubMed ID: 23497006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of PET staging in limited-stage small-cell lung cancer.
    Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
    J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
    van der Leest C; Smit EF; Baas J; Versteijlen RJ; van Walree N; Hoogsteden HC; Aerts JG
    Lung Cancer; 2012 Apr; 76(1):67-71. PubMed ID: 21996089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
    Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
    Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
    Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J
    Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer.
    Flores R; Bauer T; Aye R; Andaz S; Kohman L; Sheppard B; Mayfield W; Thurer R; Smith M; Korst R; Straznicka M; Grannis F; Pass H; Connery C; Yip R; Smith JP; Yankelevitz D; Henschke C; Altorki N;
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1619-26. PubMed ID: 24332102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
    Thomas A; Pattanayak P; Szabo E; Pinsky P
    Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme.
    Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Hanaoka T; Takayama F; Koizumi T; Kubo K; Yamanda T; Kondo R; Fushimi H; Suzuki T
    Lung Cancer; 2007 May; 56(2):207-15. PubMed ID: 17258349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with small cell lung carcinoma in Taiwan.
    Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
    Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system.
    Jhun BW; Lee KJ; Jeon K; Suh GY; Chung MP; Kim H; Kwon OJ; Sun JM; Ahn JS; Ahn MJ; Park K; Choi JY; Lee KS; Han J; Um SW
    Lung Cancer; 2013 Jul; 81(1):65-70. PubMed ID: 23523420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
    Lee YJ; Cho A; Cho BC; Yun M; Kim SK; Chang J; Moon JW; Park IK; Choi HJ; Kim JH
    Clin Cancer Res; 2009 Apr; 15(7):2426-32. PubMed ID: 19318478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
    Lopes Pegna A; Picozzi G; Mascalchi M; Maria Carozzi F; Carrozzi L; Comin C; Spinelli C; Falaschi F; Grazzini M; Innocenti F; Ronchi C; Paci E;
    Lung Cancer; 2009 Apr; 64(1):34-40. PubMed ID: 18723240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.